Gore Range Capital
Gore Range Capital is a venture capital firm focused on hands-on investing in early-stage healthcare businesses.
Business Model: B2B
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Gore Range Capital Information
Geographic Data
Address: 767 Third Avenue
City: New York
State: NY
Zip: 10017
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Gore Range Capital is a venture capital firm focused on hands-on investing in early-stage healthcare businesses. We invest in companies that have strong potential for growth, high barriers to entry, and exceptional management teams. Our approach is simple: we invest in what we know. Over the course of our respective careers the Gore Range team has built domain expertise and extensive networks across multiple areas of healthcare. Through Gore Range Capital we are channeling our capabilities to focus on our largest organ and the most visible manifestation of who we are - the skin. At Gore Range, we blend the hands-on approach of operationally focused private equity with the early-stage guidance needed in venture capital. We offer not just capital, but insights as well as operational, clinical, and scientific expertise while leveraging our deep industry relationships to position our portfolio companies for success.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 10/2018 | xMD Diagnostics | Series A | - |
| 3/2021 | Eirion Therapeutics | Series A | 0 |
| 5/2016 | Conversa Health | Seed Round | 0 |
| 4/2020 | Dorsata | Series A | 5.2M |
| 1/2019 | CoreMedica Laboratories | Venture Round | - |
| 11/2022 | Validic | Venture Round | 12M |
| 7/2016 | Medikly | Convertible Note | - |
| 1/2023 | Palvella Therapeutics | Series D | 37.7M |
| 5/2019 | Paradigm Diagnostics | Series B | 0 |
| 1/2016 | Dorsata | Seed | 1.1M |
| 4/2016 | NovaScan | Seed Round | - |
| 7/2015 | Castle Biosciences | Series F | 11.7M |
| 1/2017 | Claret Medical | Series C | - |
| 3/2021 | Eirion Therapeutics | Series A | 0 |
| 4/2020 | Dorsata | Series A | 0 |
| 5/2019 | Paradigm Diagnostics | Series B | 0 |
| 1/2019 | CoreMedica Laboratories | Venture Round | - |
| 10/2018 | xMD Diagnostics | Series A | - |
| 1/2017 | Claret Medical | Series C | - |
| 7/2016 | Medikly | Convertible Note | - |
| 5/2016 | Conversa Health | Seed Round | 0 |
| 4/2016 | NovaScan | Seed Round | - |
| 1/2016 | Dorsata | Seed Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
